The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats

• Ngā kaituhi matua: Takahiro Oguma (Author), Chiaki Kuriyama (Author), Keiko Nakayama (Author), Yasuaki Matsushita (Author), Kumiko Yoshida (Author), Satoko Kiuchi (Author), Yuka Ikenaga (Author), Yoshinobu Nakamaru (Author), Kumiko Hikida (Author), Akira Saito (Author), Kenji Arakawa (Author), Kozo Oka (Author), Kiichiro Ueta (Author), Masaharu Shiotani (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2015-04-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

To assess the impact of concomitant inhibition of sodium-glucose cotransporter (SGLT) 2 and dipeptidyl peptidase IV (DPP4) for the treatment of type 2 diabetes mellitus (T2DM), the effect of combined treatment with canagliflozin, a novel SGLT2 inhibitor, and teneligliptin, a DPP4 inhibitor, on gluco...